Douglas Crandell, Eric Furman, Ph.D. Drug development programs face unique challenges in demonstrating the safety and effectiveness of drugs for treating rare diseases. The FDA’s Accelerating Rare ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback